Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis

Takashi Muramatsu1

  • 1Department of Biochemistry, Nagoya University School of Medicine, Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan. tmurama@med.nagoya-u.ac.jp

Journal of Biochemistry
|September 3, 2002
PubMed

Insights

Midkine (MK) and pleiotrophin (PTN) are proteins involved in cell growth and organ development. Their elevated expression in tumors and after injury suggests roles in disease and potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Midkine (MK) and pleiotrophin (PTN) are structurally similar low molecular weight proteins.
  • They regulate cell growth, survival, migration, neurogenesis, and epithelial-mesenchymal interactions.
  • Protein-tyrosine phosphatase zeta (PTPzeta) acts as a receptor for MK and PTN, activating downstream ERK and PI3 kinase signaling.

Purpose of the Study:

  • To explore the biological functions and potential applications of Midkine (MK) and pleiotrophin (PTN).
  • To investigate the binding characteristics of MK to its receptor PTPzeta.
  • To highlight the significance of MK and PTN in pathological conditions and therapeutic strategies.

Main Methods:

  • Structural analysis of MK and PTN.
  • Investigation of cell signaling pathways (ERK, PI3 kinase).
  • Binding affinity studies using chondroitin sulfate structures.

Main Results:

  • MK and PTN promote cell growth, survival, and migration.
  • The E unit of chondroitin sulfate on PTPzeta provides a high-affinity binding site for MK.
  • Increased expression of MK and PTN is observed in human tumors and following ischemic injury.

Conclusions:

  • MK and PTN are implicated in tumor progression and ischemic injury.
  • Their roles in cell migration and inflammation suggest involvement in neointima formation and renal injury.
  • MK and PTN hold potential as tumor markers, therapeutic targets, and in treating neurodegenerative diseases, enhancing in vitro development, and preventing HIV infection.

Related Concept Videos

Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.